ROVATIN 40 TAB contains Rosuvastatin Calcium equivalent to 40 mg of Rosuvastatin, a high-potency statin used for aggressive lipid management. It is indicated for patients with severe hypercholesterolemia, high cardiovascular risk, or genetic lipid disorders. Manufactured by Bluepill Express under stringent GMP guidelines, ROVATIN 40 offers strong LDL reduction, supporting effective control of cholesterol levels and prevention of atherosclerotic cardiovascular events.

This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.

ROVATIN 40 TAB is a pharmaceutical formulation containing Rosuvastatin Calcium equivalent to 40 mg of Rosuvastatin, a powerful HMG-CoA reductase inhibitor designed for advanced lipid-lowering therapy. This product is intended for patients requiring high-intensity statin treatment due to severe dyslipidemia or elevated cardiovascular risk. Rosuvastatin is a synthetic statin that functions by selectively inhibiting the enzyme responsible for endogenous cholesterol synthesis in the liver, leading to significant reductions in total cholesterol, low-density lipoprotein cholesterol (LDL-C), and triglycerides, along with a concurrent increase in high-density lipoprotein cholesterol (HDL-C).

The 40 mg dosage of ROVATIN is typically reserved for patients who fail to achieve lipid targets with lower doses or those at immediate risk for cardiovascular events, such as those with familial hypercholesterolemia, metabolic syndrome, diabetes mellitus, or existing coronary artery disease. Clinical evidence supports the efficacy of Rosuvastatin 40 mg in reducing LDL-C levels by over 50%, providing a reliable therapeutic option for aggressive cholesterol management protocols and secondary prevention of myocardial infarction, stroke, or revascularization procedures.

ROVATIN 40 TAB is manufactured by Bluepill Express in state-of-the-art facilities compliant with WHO-GMP, ISO, and other global regulatory norms. Advanced formulation techniques ensure consistent bioavailability, rapid onset of action, and once-daily oral administration for improved adherence. The product is subjected to rigorous in-process quality control and final batch testing, including content uniformity, dissolution, stability studies, and microbial limit testing, ensuring that each tablet meets international pharmacopoeial standards (USP/BP/EP).

This formulation is suitable for international distribution and registration, supported by full technical documentation including Certificate of Analysis (COA), Stability Data, Manufacturing License, and CTD-format dossiers for regulated markets. Bluepill Express also offers customized packaging options including alu-alu blister packs, multilingual labeling, and serialization as per client country compliance.

The safety profile of ROVATIN 40 TAB aligns with that of high-dose statin therapy. It is generally well tolerated; however, like all statins, it may cause side effects in a minority of patients, such as elevated liver enzymes, muscle aches, or rare instances of myopathy. Physicians are advised to conduct periodic liver function and creatine kinase assessments in long-term therapy cases. The product should not be used in patients with active liver disease, pregnancy, or breastfeeding women.

ROVATIN 40 TAB underscores Bluepill Express’s commitment to cardiovascular health and evidence-based medicine. By offering a robust, export-ready statin formulation, Bluepill Express empowers healthcare providers and international partners to deliver meaningful clinical outcomes in the prevention of life-threatening heart and vascular conditions. Its presence in the cardiovascular portfolio signifies a complete therapeutic approach to cholesterol management—from moderate to very high-risk patients.